ArticlePhytotherapy research : PTR2026

Amentoflavone, a Preferentially TGF-β Receptor 1 Inhibitor, Alleviates Cardiac Remodeling and Dysfunction Through Modulating the TGF-β/Smad and MAPK Signaling Pathways.

Jiangjiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.